mitomycin has been researched along with Conjunctivitis, Viral in 2 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Conjunctivitis, Viral: Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report the use of photorefractive keratectomy (PRK) with mitomycin-C (MMC) to treat concomitant myopia and visually significant infiltrates associated with epidemic keratoconjunctivitis (EKC)." | 7.78 | Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis. ( Alevi, D; Barsam, A; Donnenfeld, ED; Kruh, J; Perry, HD; Prince, J, 2012) |
| "To report the use of photorefractive keratectomy (PRK) with mitomycin-C (MMC) to treat concomitant myopia and visually significant infiltrates associated with epidemic keratoconjunctivitis (EKC)." | 3.78 | Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis. ( Alevi, D; Barsam, A; Donnenfeld, ED; Kruh, J; Perry, HD; Prince, J, 2012) |
| "To assess visual results and compare methods of measuring central corneal thickness (CCT) and corneal opacity thickness (COT) in patients with corneal opacities induced by epidemic keratoconjunctivitis (EKC) and treated with phototherapeutic keratectomy (PTK) using low-dose mitomycin C (MMC)." | 3.77 | Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis. ( Allemann, N; Campos, M; Ferraz, CA; Hazarbassanov, RM; Yamazaki, ES, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamazaki, ES | 1 |
| Ferraz, CA | 1 |
| Hazarbassanov, RM | 1 |
| Allemann, N | 1 |
| Campos, M | 1 |
| Alevi, D | 1 |
| Barsam, A | 1 |
| Kruh, J | 1 |
| Prince, J | 1 |
| Perry, HD | 1 |
| Donnenfeld, ED | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phototherapeutic Keratectomy With Mitomycin C in Adenoviral Infiltrates[NCT00492245] | 30 participants (Anticipated) | Interventional | 2006-04-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for mitomycin and Conjunctivitis, Viral
| Article | Year |
|---|---|
Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis.
Topics: Adenovirus Infections, Human; Adolescent; Adult; Aged; Conjunctivitis, Viral; Contrast Sensitivity; | 2011 |
Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis.
Topics: Aberrometry; Adenoviridae; Adenovirus Infections, Human; Administration, Topical; Adult; Alkylating | 2012 |